Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly short-term debt is $11.69 Billion with a quarter-over-quarter change of -33.04%. Short-term debt includes all borrowings and debt obligations due within one year, including the current portion of long-term debt, commercial paper, and credit facilities.
Reported quarterly short-term debt; no daily interpolation.
$11.69B
$11.69 Billion
-33.04%
vs. $17.46B prior quarter
96
Quarters of data available
| Period | Short-Term Debt | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $11.69B | −$5.77B | -33.04% |
| Quarter ended Mar 2026 | $17.46B | +$8.96B | +105.53% |
| Quarter ended Dec 2025 | $8.49B | +$2.11B | +33.00% |
| Quarter ended Sep 2025 | $6.39B | −$5.14B | -44.59% |
| Quarter ended Jun 2025 | $11.53B | −$2.37B | -17.06% |
| Quarter ended Mar 2025 | $13.90B | +$7.91B | +132.27% |
| Quarter ended Dec 2024 | $5.98B | +$1.52B | +34.09% |
| Quarter ended Sep 2024 | $4.46B | −$5.39B | -54.72% |
| Quarter ended Jun 2024 | $9.86B | +$1.30B | +15.26% |
| Quarter ended Mar 2024 | $8.55B | +$5.10B | +147.75% |
| Quarter ended Dec 2023 | $3.45B | −$419.00M | -10.83% |
| Quarter ended Oct 2023 | $3.87B | −$7.83B | -66.93% |
| Quarter ended Jul 2023 | $11.70B | −$6.28B | -34.92% |
| Quarter ended Apr 2023 | $17.98B | +$5.22B | +40.95% |
| Quarter ended Dec 2022 | $12.76B | +$8.33B | +188.34% |
| Quarter ended Oct 2022 | $4.42B | +$119.00M | +2.76% |
| Quarter ended Jul 2022 | $4.30B | +$8.00M | +0.19% |
| Quarter ended Apr 2022 | $4.30B | +$531.00M | +14.10% |
| Quarter ended Dec 2021 | $3.77B | −$32.00M | -0.84% |
| Quarter ended Oct 2021 | $3.80B | +$625.00M | +19.70% |
| Quarter ended Jul 2021 | $3.17B | −$177.00M | -5.28% |
| Quarter ended Apr 2021 | $3.35B | +$719.00M | +27.33% |
| Quarter ended Dec 2020 | $2.63B | −$2.45B | -48.19% |
| Quarter ended Sep 2020 | $5.08B | −$254.00M | -4.76% |
| Quarter ended Jun 2020 | $5.33B | +$3.14B | +143.47% |
| Quarter ended Mar 2020 | $2.19B | +$988.00M | +82.20% |
| Quarter ended Dec 2019 | $1.20B | −$1.10B | -47.72% |
| Quarter ended Sep 2019 | $2.30B | +$580.00M | +33.74% |
| Quarter ended Jun 2019 | $1.72B | +$11.00M | +0.64% |
| Quarter ended Mar 2019 | $1.71B | −$1.09B | -38.91% |
| Quarter ended Dec 2018 | $2.80B | +$1.02B | +57.70% |
| Quarter ended Sep 2018 | $1.77B | −$905.00M | -33.79% |
| Quarter ended Jul 2018 | $2.68B | −$18.00M | -0.67% |
| Quarter ended Apr 2018 | $2.70B | −$1.21B | -30.98% |
| Quarter ended Dec 2017 | $3.91B | −$4.58B | -54.00% |
| Quarter ended Oct 2017 | $8.49B | +$1.28B | +17.78% |
| Quarter ended Jul 2017 | $7.21B | +$1.85B | +34.62% |
| Quarter ended Apr 2017 | $5.36B | +$671.00M | +14.33% |
| Quarter ended Dec 2016 | $4.68B | +$1.24B | +36.04% |
| Quarter ended Oct 2016 | $3.44B | +$1.74B | +101.58% |
| Quarter ended Jul 2016 | $1.71B | −$1.41B | -45.19% |
| Quarter ended Apr 2016 | $3.12B | −$3.89B | -55.51% |
| Quarter ended Dec 2015 | $7.00B | +$1.33B | +23.38% |
| Quarter ended Sep 2015 | $5.68B | +$455.00M | +8.71% |
| Quarter ended Jun 2015 | $5.22B | +$1.18B | +29.10% |
| Quarter ended Mar 2015 | $4.04B | +$407.00M | +11.19% |
| Quarter ended Dec 2014 | $3.64B | +$1.52B | +72.01% |
| Quarter ended Sep 2014 | $2.12B | −$1.70B | -44.62% |
| Quarter ended Jun 2014 | $3.82B | −$130.00M | -3.29% |
| Quarter ended Mar 2014 | $3.95B | −$903.00M | -18.61% |
| Quarter ended Dec 2013 | $4.85B | −$507.00M | -9.46% |
| Quarter ended Sep 2013 | $5.36B | +$20.00M | +0.37% |
| Quarter ended Jun 2013 | $5.34B | +$810.00M | +17.88% |
| Quarter ended Mar 2013 | $4.53B | −$147.00M | -3.14% |
| Quarter ended Dec 2012 | $4.68B | −$747.00M | -13.77% |
| Quarter ended Sep 2012 | $5.42B | −$617.00M | -10.22% |
| Quarter ended Jul 2012 | $6.04B | −$399.00M | -6.20% |
| Quarter ended Apr 2012 | $6.44B | −$219.00M | -3.29% |
| Quarter ended Dec 2011 | $6.66B | +$1.33B | +25.01% |
| Quarter ended Oct 2011 | $5.33B | +$280.00M | +5.55% |
| Quarter ended Jul 2011 | $5.05B | −$3.53B | -41.15% |
| Quarter ended Apr 2011 | $8.57B | +$958.00M | +12.58% |
| Quarter ended Dec 2010 | $7.62B | +$4.77B | +167.92% |
| Quarter ended Oct 2010 | $2.84B | −$872.00M | -23.47% |
| Quarter ended Jul 2010 | $3.71B | −$329.00M | -8.14% |
| Quarter ended Apr 2010 | $4.04B | −$2.27B | -35.99% |
| Quarter ended Dec 2009 | $6.32B | +$2.98B | +89.11% |
| Quarter ended Sep 2009 | $3.34B | −$2.09B | -38.53% |
| Quarter ended Jun 2009 | $5.43B | −$587.00M | -9.75% |
| Quarter ended Mar 2009 | $6.02B | +$2.29B | +61.36% |
| Quarter ended Dec 2008 | $3.73B | −$2.51B | -40.24% |
| Quarter ended Sep 2008 | $6.25B | +$1.09B | +21.12% |
| Quarter ended Jun 2008 | $5.16B | +$906.00M | +21.32% |
| Quarter ended Mar 2008 | $4.25B | +$1.79B | +72.55% |
| Quarter ended Dec 2007 | $2.46B | −$801.00M | -24.54% |
| Quarter ended Sep 2007 | $3.26B | −$1.21B | -26.98% |
| Quarter ended Jul 2007 | $4.47B | −$212.00M | -4.53% |
| Quarter ended Apr 2007 | $4.68B | +$103.00M | +2.25% |
| Quarter ended Dec 2006 | $4.58B | +$4.22B | +1164.92% |
| Quarter ended Oct 2006 | $362.00M | −$292.00M | -44.65% |
| Quarter ended Jul 2006 | $654.00M | −$174.00M | -21.01% |
| Quarter ended Apr 2006 | $828.00M | +$160.00M | +23.95% |
| Quarter ended Dec 2005 | $668.00M | +$390.00M | +140.29% |
| Quarter ended Oct 2005 | $278.00M | −$26.00M | -8.55% |
| Quarter ended Jul 2005 | $304.00M | −$15.00M | -4.70% |
| Quarter ended Apr 2005 | $319.00M | +$39.00M | +13.93% |
| Quarter ended Dec 2004 | $280.00M | −$174.00M | -38.33% |
| Quarter ended Sep 2004 | $454.00M | −$37.00M | -7.54% |
| Quarter ended Jun 2004 | $491.00M | −$103.00M | -17.34% |
| Quarter ended Mar 2004 | $594.00M | −$545.00M | -47.85% |
| Quarter ended Dec 2003 | $1.14B | −$885.00M | -43.73% |
| Quarter ended Sep 2003 | $2.02B | −$1.23B | -37.80% |
| Quarter ended Jun 2003 | $3.25B | +$1.15B | +54.73% |
| Quarter ended Mar 2003 | $2.10B | −$14.00M | -0.66% |
| Quarter ended Dec 2002 | $2.12B | −$264.00M | -11.09% |
| Quarter ended Sep 2002 | $2.38B | N/A | N/A |